ROK Global PLC, the mobile and web technology, applications and services company, has announced the appointment of Paolo Fidanza, formerly head of US subsidiary ROK Americas, as CEO, with immediate effect.
Jonathan Kendrick remains as Chairman of ROK Global PLC.
Commenting, Kendrick said “The growth of ROK Global, particularly in the United States, has resulted in the need to separate the Chairman and CEO roles and now is the time for a dedicated CEO to be appointed. Paolo is a proven and dynamic achiever who is based in our Los Angeles office and will now concentrate 100% of his efforts on driving ROK Global forward as we continue the development and deployment of our growing portfolio of technologies, applications and services worldwide.”
ROK Global PLC was co-founded by US Billionaire John Paul DeJoria and UK-based serial entrepreneur, Jonathan Kendrick.
In addition to being the co-founder of ROK, John Paul DeJoria is Chairman and CEO of John Paul Mitchell Systems, the producer and manufacturer of Paul Mitchell hair care products and is also co-founder of Patron Tequila, the world’s leading premium tequila brand.
ROK Global PLC has pioneered many new technologies in the rapidly-evolving mobile and web space in addition to high quality mass-market Mobile TV (which can be streamed, live and on-demand, over 2.5G GPRS as well as 3G and Wi-Fi), to include mobile security technologies which it licenses to law enforcement agencies, multi-language text-to-speech technologies as well as the highly innovative ‘JP Selects’ e-commerce market place for eco-friendly and sustainable brands and products.
For more information:
Safe Harbor Statement: The statements contained herein which are not historical are forward- looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward- looking statements, including, but not limited to, certain delays beyond the company's control with respect to market acceptance of new technologies or products, delays in testing and evaluation of products, and other risks detailed from time to time.